<!DOCTYPE html>
<html>
<head>
  <!-- Site made with Mobirise Website Builder v3.11.1, https://mobirise.com -->
  <meta charset="UTF-8">
  <meta http-equiv="X-UA-Compatible" content="IE=edge">
  <meta name="generator" content="Mobirise v3.11.1, mobirise.com">
  <meta name="viewport" content="width=device-width, initial-scale=1">
  <link rel="shortcut icon" href="assets/images/logo.png" type="image/x-icon">
  <meta name="description" content="Site Builder Description">
  <title>Site Builder Title</title>
  <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Lora:400,700,400italic,700italic&amp;subset=latin">
  <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Montserrat:400,700">
  <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Raleway:100,100i,200,200i,300,300i,400,400i,500,500i,600,600i,700,700i,800,800i,900,900i">
  <link rel="stylesheet" href="assets/bootstrap-material-design-font/css/material.css">
  <link rel="stylesheet" href="assets/tether/tether.min.css">
  <link rel="stylesheet" href="assets/bootstrap/css/bootstrap.min.css">
  <link rel="stylesheet" href="assets/soundcloud-plugin/style.css">
  <link rel="stylesheet" href="assets/dropdown/css/style.css">
  <link rel="stylesheet" href="assets/animate.css/animate.min.css">
  <link rel="stylesheet" href="assets/theme/css/style.css">
  <link rel="stylesheet" href="assets/mobirise/css/mbr-additional.css" type="text/css">
  
  
  
</head>
<body>
<section id="menu-1f">

    <nav class="navbar navbar-dropdown bg-color transparent">
        <div class="container">

            <div class="mbr-table">
                
                <div class="mbr-table-cell">

                    <button class="navbar-toggler pull-xs-right hidden-md-up" type="button" data-toggle="collapse" data-target="#exCollapsingNavbar">
                        <div class="hamburger-icon"></div>
                    </button>

                    <ul class="nav-dropdown collapse pull-xs-right nav navbar-nav navbar-toggleable-sm" id="exCollapsingNavbar"><li class="nav-item"><a class="nav-link link" href="index.html">HOME&nbsp;</a></li><li class="nav-item"><a class="nav-link link" href="Introduction.html">OVERVIEW&nbsp;</a></li><li class="nav-item"><a class="nav-link link" href="Programme.html">PROGRAMME&nbsp;</a></li></ul>
                    <button hidden="" class="navbar-toggler navbar-close" type="button" data-toggle="collapse" data-target="#exCollapsingNavbar">
                        <div class="close-icon"></div>
                    </button>

                </div>
            </div>

        </div>
    </nav>

</section>

<section class="engine"><a rel="external" href="https://mobirise.com">mobirise.com</a></section><section class="mbr-section mbr-after-navbar" id="msg-box5-1p" style="background-color: rgb(255, 255, 255); padding-top: 80px; padding-bottom: 0px;">

    
    <div class="container">
        <div class="row">
            <div class="mbr-table-md-up">

              <div class="mbr-table-cell mbr-right-padding-md-up mbr-valign-top col-md-7 image-size" style="width: 20%;">
                  <div class="mbr-figure"><img src="assets/images/blanco-1400x1934.jpg"></div>
              </div>

              


              <div class="mbr-table-cell col-md-5 text-xs-center text-md-left content-size">
                  
                  <div class="lead">

                    <p><strong>JANUARY</strong> <strong>10</strong><br><br><span style="font-size: 1.07rem; line-height: 1.5;"><strong>11:00-11:30	Welcome message and general information.</strong> Antonio Cuadrado</span><br><br><strong>11:30-13:00	SESION 1. </strong>Chair: Anna Grochot-Przęczek<br><br><strong>• NRF2-CEBPB cooperativity in transcriptional regulation.</strong> Hozumi Motohashi <em><a href="Hozumi Motohashi.html" target="_blank">(Abstract &amp; Biosketch)</a></em><br><br><strong>•	Peroxiporins and NRF2. </strong>Ana Čipak Gašparović <em><a href="Ana Čipak Gašparović.html" target="_blank">(Abstract &amp; Biosketch)</a></em><br><br><strong>•	NRF2 activity is impaired in a DPR model of C9orf72-related ALS through non-classical mechanisms.</strong> Ana I Rojo&nbsp;<em><a href="Ana I Rojo.html" target="_blank">(Abstract &amp; Biosketch)</a></em><br><br><strong>•	The NRF2-KEAP1 signaling pathway as a pharmacological target in cardiovascular and neuropsychiatric complications in response to environmental risk factors traffic noise and particulate matter. </strong>Andreas Daiber&nbsp;<em><a href="Andreas Daiber.html" target="_blank">(Abstract &amp; Biosketch)</a></em><br><br><strong>•	NRF2 Associated Immune Evasion in Non-Small Cell Lung  Cancer and Squamous Malignancies.</strong> Anna-Liisa Levonen <em><a href="Anna-Liisa Levonen.html" target="_blank">(Abstract &amp; Biosketch)</a></em><br><br><strong>•&nbsp;NRF2 as a Pharmacological Target in Renal diseases.&nbsp;</strong>Juan Antonio Moreno<a href="JA Moreno.html" target="_blank"> (Abstract &amp; Biosketch)</a><br><br><strong>13:00-14:00</strong>	Breakout rooms and lunch<br><br><strong>14:00-15:30	SESION 2. </strong>Chair: Ana I. Rojo<br><br><strong>•	Novel atypical functions of Nrf2 and Keap1 in endothelial cells.</strong> Anna Grochot-Przęczek<em>&nbsp;<a href="Anna Grochot-Przęczek.html" target="_blank">(Abstract &amp; Biosketch)</a></em><br><br>•	<strong>The NRF2-KEAP1 Signaling Pathway as a Pharmacological Target in Neurodegenerative diseases.</strong> Antonio Cuadrado&nbsp;<em><a href="Antonio Cuadrado.html" target="_blank">(Abstract &amp; Biosketch)</a></em><br><br><strong>•	<em>In silico</em> based development of the activators of NRF2-KEAP1 signaling pathway for the treatment of the dermatological disorders. </strong>Arie Gruzman, Shirin Kahremany and Guy Cohen<em><a href="Arie Gruzman.html" target="_blank">&nbsp;(Abstract &amp; Biosketch)</a></em><br><br><strong>•	Deciphering the inflammatory role of lung myeloid cells in response to Streptococcus pneumoniae infection. </strong>Belén de Andrés and Mª Luisa Gaspar&nbsp;<em><a href="Belen Muguruza.html" target="_blank">(Abstract &amp; Biosketch)</a></em><br><br><strong>•	Targeting Intracellular Beta-Amyloid Accumulation: On the path for Preventing Alzheimer’s Disease.</strong> Cláudia Guimas Almeida&nbsp;<em><a href="Claudia Almeida.html" target="_blank">(Abstract &amp; Biosketch)</a></em><br><br><strong>• Sorafenib downregulates nuclear factor E2-related factor 2 (Nrf2)-regulated thioredoxin 1 (Trx1) expression in liver cancer cells.</strong>&nbsp;Jordi Muntané&nbsp;<a href="Jordi Muntane.html" target="_blank">&nbsp;(Abstract &amp; Biosketch)</a><br><strong><br></strong><strong>15:30-16:00</strong>	Coffee break. Breakout rooms<br><br><strong>16:00-17:30	SESION 3.</strong> Chair: Brigitte Winklhofer-Roob<br><br><strong>•	NRF2 and dendritic cell tolerogenicity. </strong>Đorđe Miljković<em>&nbsp;<a href="Đorđe Miljković.html">(Abstract &amp; Biosketch)</a></em><br><br><strong>•	AMP(K)lifying Nrf2: The crosstalk between Nrf2 and the metabolic master hub AMPK. </strong>Elke H Heiss <em><a href="Elke Heiss.html">(Abstract &amp; Biosketch)</a></em><br><br><strong>•	Sulforaphane prevents age-associated cardiac, muscular, and skin dysfunction through Nrf2 signaling. </strong>Eugenia Carvalho&nbsp;<em><a href="Eugenia Carbalho.html">(Abstract &amp; Biosketch)</a></em><br><br><strong>•	A brief overview of small molecule inhibitors of Keap1 and β-TrCP as Nrf2 inducers.</strong> Geoff Wells <em>(<a href="Geoffrey Wells.html" target="_blank">Abstract &amp; Biosketch)</a></em><br><br><strong>•	The expression pattern of inflammation and redox genes in the blood of mild AD patients – focus on the molecular signatures of NFkB and NRF2.</strong> Gina Manda&nbsp;<em><a href="Gina Manda.html" target="_blank">(Abstract &amp; Biosketch)</a></em><br><br><strong>•&nbsp;Therapeutic effects of HYCOs, hybrid molecules that activate Nrf2/HO-1 and simultaneously release carbon monoxide.&nbsp;</strong>Roberto Motterlini and Roberta Foresti&nbsp;&nbsp;<a href="Roberto Motterlini.html" target="_blank">(Abstract &amp; Biosketch)</a><br><strong><br></strong><strong>17:30-18:00	</strong>Breakout rooms<br><br><strong>JANUARY</strong> <strong>11</strong><br><br><strong>  9:30-11:15 SESION 4. </strong>Chair: Guy Cohen<br><br><strong>• Lack of transcriptionally active Nrf2 mitigates colon dysfunction in female mice – the role of estrogen receptors.</strong> Aleksandra Piechota-Polanczyk<em>&nbsp;<a href="Aleksandra Piechota.html" target="_blank">(Abstract &amp; Biosketch)</a></em><br><br><strong>•	The anti-inflammatory role of Nrf2 activation.</strong> Albena T. Dinkova-Kostova&nbsp;<em><a href="Albena DinkovaKostova.html" target="_blank">(Abstract &amp; Biosketch)</a></em><br><br><strong>•	Translational implications of Nrf2 signaling in the thyroid. </strong>Gerasimos P. Sykiotis<em>&nbsp;<a href="Gerasimos Sykiotis.html" target="_blank">(Abstract &amp; Biosketch)</a></em><br><br><strong>•	Nrf2 in stress, aging and age-related diseases.</strong> Ioannis Trougakos&nbsp;<em><a href="Ioannis Trougakos.html" target="_blank">(Abstract &amp; Biosketch)</a></em><br><br><strong>•	Quercetin analogues and derivatives for pharmacological regulation of NRF2.</strong> Kateřina Valentová <em><a href="Kateřina Valentová.html" target="_blank">(Abstract &amp; Biosketch)</a></em><br><em><a href="Kateřina Valentová.html" target="_blank"><br></a></em><strong>•&nbsp;Transcriptional Activation of NRF2 Defense Genes is Attenuated in Vascular Cells under Physiological Normoxia: Consequences for Reperfusion Injury.&nbsp;</strong>Giovanni E. Mann&nbsp;<a href="Giovanni Mann.html" target="_blank">&nbsp;(Abstract &amp; Biosketch)</a><br><br><strong>•&nbsp;CO-mediated cytoprotection is dependent on cell metabolism modulation – implication on neuronal differentiation, anti-inflammation role and prevention of cell death.&nbsp;</strong>Helena L.A. Vieira <a href="Helena Vieira.html" target="_blank">(Abstract)</a><br><br><strong>11:15-11-30</strong>	Coffee break, Breakout rooms <br><br><strong>11:30-13:00	SESION 5.</strong> Chair Brigitta Buttari<br><strong><br>•	Mild hypothermia alleviates reductive stress, a root cause of ischemia reperfusion injury</strong>. Kattri-Liis Eskla&nbsp;<a href="Katri liis.html" target="_blank">(Abstract &amp; Biosketch)</a><br><br><strong>•	Role of poly(ADP-ribosyl)ation in oxidative stress-induced cell death and inflammatory signaling.</strong> László Virág<em>&nbsp;<a href="László Virág.html" target="_blank">(Abstract &amp; Biosketch)</a></em><br><br><strong>•	Targeting the BACH1-NRF2 axis.</strong> Laureano de la Vega&nbsp;<a href="laureano de la Vega.html">(Abstract &amp; Biosketch)</a><br><br><strong>•	NRF2 and ROS in Cancer.</strong> Lidija Milkovic&nbsp;<a href="Lidija Milkovic.html" target="_blank">(Abstract &amp; Biosketch)</a><br><br><strong>•	Implication of Nrf2/heme oxygenase-1 pathway in articular and skin diseases. </strong>M Carmen Montesinos y M Luisa Ferrándiz&nbsp;<a href="Montesions y Ferrandiz.html" target="_blank">(Abstract &amp; Biosketch)</a><br><br><strong>•&nbsp;Mitochondrial metabolism and endogenous antioxidants under NRF2 activation in the mechanism of neuroprotection in neurodegenerative disorders and epilepsy.&nbsp;</strong>Andrey Y. Abramov&nbsp;&nbsp;<a href="Andrey Abramov.html" target="_blank">(Abstract &amp; Biosketch)</a><br><br><strong>13:00-14:00</strong>	Breakout rooms and lunch<br><br><strong>14:00-15:45 SESION 6.</strong> Chair: Gina Manda<br><br><strong>•	NF1086: an NRF2 inducer with potential interest in Alzheimer´s. </strong>Manuela G. Lopez, E. del Sastre, C. Fernández Mendivil and I. Rodriguez-Franco<a href="Manuela.G.Lopez.html" target="_blank"> (Abstract &amp; Biosketch)</a><br><br><strong>•	Dipeptidyl peptidase 3, competitive interactor of KEAP1 protein. </strong>Mihaela Matovina&nbsp;<a href="Mihaela Matovina.html" target="_blank">(Abstract &amp; Biosketch)</a><br><br><strong>•	Microenvironmental Nrf2 supports growth of the orthotopic pancreatic tumors and modulates the efficacy of chemotherapy. </strong>Monika A. Jakubowska&nbsp;<a href="Monika Jakubowska.html" target="_blank">(Abstract &amp; Biosketch)</a><br><br><strong>•	Nrf2 signaling in health and disease. </strong>Niki Chondrogianni&nbsp;<a href="Niki Chondrogianni.html" target="_blank">(Abstract &amp; Biosketch)</a><br><br><strong>•	The bile acid ethylidene derivatives as valuable compounds for the potential treatment of NRF2-related diseases.</strong> Synthesis and biological activity. Srđan Bjedov&nbsp;<a href="Srdjan Bjedov.html" target="_blank">(Abstract &amp; Biosketch)</a><br><br><strong>• The Protective Role of NRF2 Signaling Against NLRP3 Inflammasome Activation in Brain.&nbsp;</strong>Kemal Ugur Tufekci <a href="Kemal Tufekci.html" target="_blank">(Abstract &amp; Biosketch)</a><br><br><strong>•&nbsp;Targeting Nrf2 to control CD4+ T cells contribution to the gut- brain axis.&nbsp;</strong><span style="font-size: 1.07rem; line-height: 1.5;">Michel Edwar Mickael <a href="Michel Edwar.html" target="_blank">(Abstract &amp; Biosketch)</a></span><br><strong><br></strong><strong>15:45-16:00</strong>	Coffee break, Breakout rooms<br><br><strong>16:00-17:30	SESION 7.</strong> Chair: Manuela G. López<br><br><strong>•	Phytohormones Strigolactones: Their Promising Therapeutic Roles in Inflammation Related Noncommunicable Diseases through Modulating NRF2-KEAP1, BDNF-TrkB and NLRP3 Signaling Cascades. </strong>Tugba Boyunegmez Tumer&nbsp;<a href="Tugba Tumer.html" target="_blank">(Abstract &amp; Biosketch)</a><br><br><strong>•	Flavonoids - mere antioxidants or specific ligands for biological targets?.</strong>Vladimír Křen&nbsp;<a href="Vladimir Kren.html" target="_blank">(Abstract &amp; Biosketch)</a><br><br><strong>•&nbsp;Increased ROS can improve cell survival: stress response PACOS.&nbsp;</strong>Irina Milisav<a href="Irina Milisav.html" target="_blank">&nbsp;(Abstract &amp; Biosketch)</a><br><br><strong>•&nbsp;The nanotechnology to improve the treatment of Alzheimer’s and other neurological diseases.</strong>&nbsp;Joana A. Loureiro, Maria do Carmo Pereira&nbsp;<a href="Joana Loureiro.html" target="_blank">(Abstract &amp; Biosketch)</a><br><br><strong>• Cholesterol Mediated Nrf2 Status in NASH Development: Role of α-Tocopherol.</strong>&nbsp;Nesrin Kartal Ozer<a href="Nesrin Ozer.html" target="_blank">&nbsp;(Abstract &amp; Biosketch)</a><br><br><strong>•&nbsp;Nrf2 signaling: a double-edged sword in metals toxicity.&nbsp;</strong>Aleksandra Buha Djordjevic&nbsp;<a href="Aleksandra Buha.html" target="_blank">(Abstract &amp; Biosketch)</a><br><br><strong>17:30-18:00</strong>&nbsp;Breakout rooms<br><br><strong>18:00-18:30</strong> Round table and Concluding remarks<br></p>

                  </div>

                  
              </div>


              

            </div>
        </div>
    </div>

</section>


  <script src="assets/web/assets/jquery/jquery.min.js"></script>
  <script src="assets/tether/tether.min.js"></script>
  <script src="assets/bootstrap/js/bootstrap.min.js"></script>
  <script src="assets/smooth-scroll/SmoothScroll.js"></script>
  <script src="assets/dropdown/js/script.min.js"></script>
  <script src="assets/touchSwipe/jquery.touchSwipe.min.js"></script>
  <script src="assets/viewportChecker/jquery.viewportchecker.js"></script>
  <script src="assets/theme/js/script.js"></script>
  
  
  <input name="animation" type="hidden">
  </body>
</html>